醫(yī)用可降解血管支架臨床研究進(jìn)展

醫(yī)用可降解血管支架臨床研究進(jìn)展Advances in clinical research of biodegradable stents

心血管疾病已成為危害國人身體健康的第一大疾病，介入治療已成為患者的重要選擇，植入血管支架被認(rèn)為是目前最便捷有效的技術(shù)。本綜述在簡單介紹經(jīng)皮冠脈介入治療的發(fā)展歷程的基礎(chǔ)上，綜合比較了美國雅培公司研發(fā)的生物可吸收高分子支架以及德國百多力公司研發(fā)的生物可降解鎂合金支架的一系列隨機(jī)臨床試驗(yàn)數(shù)據(jù)，總結(jié)了可降解吸收支架目前存在的缺陷并分析了其未來的發(fā)展趨勢。

Cardiovascular disease has become the first major disease that is harmful to people's health, Vascular stents and other percutaneous coronary interventions are considered the most important and effective treatment technology of cardiovascular disease. In this review, we simply introduce the development about percutaneous coronary interventions, compare a series of randomized clinical trial data of bioabsorbable vascular stents developed by Abbott of the United States and absorbable magnesium stents developed by Biotronik of Germany, summarize the shortcomings and analyze trend in the future of absorbable stents.

全文下載：http://pan.baidu.com/s/1i4SCMrj